Merck Life Science has unveiled its Formulation & Technology Centre in Turbhe, Navi Mumbai. As a key part of Merck’s global R&D network, this next-generation facility will serve as a hub for industry collaboration, equipping pharmaceutical companies with advanced tools to optimise drug formulation and accelerate time-to-market across India, APAC, Middle East, and Africa.
The Formulation & Technology Centre intends to function as a technology storefront, offering advanced formulation and processing solutions to address the growing demand for complex drug formulations. More than being just a lab; it is a space where knowledge meets practice.
The facility is designed to bridge the gap between research and commercial production, helping pharmaceutical manufacturers navigate patent challenges and enhance their product pipelines. Customers will have access to hands-on training, technical consulting, and tailored solutions designed to tackle challenges in formulation development, production scaling, and troubleshooting.
Dr Jitendra Kumar Managing Director, Biotechnology Industry Research Assistance Council (BIRAC) and Archana Jatkar, Associate Secretary General, Indian Pharmaceutical Alliance attended the launch event virtually of the Formulation & Technology Centre, while key dignitaries, including Achim Fabig, Consul General, German Consulate Mumbai; Stefan Halusa, Director General, Indo-German Chamber of Commerce; Makarand Avachat, Executive Vice President, Pharma Research, Lupin Ltd. joined Merck’s leadership team.
Pratima Reddy, Country Speaker for Merck India & MD, Merck Specialties, Dhananjay Singh, Managing Director - Life Science, Head of Science and Lab Solutions, India at Merck Life Science, Aditya Sharma, Head of Process Solutions, India Region Dr. Alessandra Ambruosi, Director & Head of Solid Formulations & Pharm Materials R&D, Merck Life Science and Dr Hemgir Gosavi, Head of Formulation & Technology Center, R&D- Solid formulation, Merck Life Science represented the India leadership team at Merck to celebrate this occasion.
The Centre reinforces the company’s commitment to industry-academia collaboration, sustainability and customer-centric innovation. By expanding its capabilities, Merck aims to empower scientists, researchers, and pharmaceutical manufacturers with technical consulting, tailored solutions, and expert-led training programs that support advanced drug formulation and development. By supporting our customers and partners in their journey, we are contributing to the global advancement of pharmaceutical sciences.
